Stereospecific in vitro and in vivo effects of the new sinus node inhibitor (+)-S 16257

Author： Thollon C. Bidouard J.-P. Cambarrat C. Lesage L. Reure H. Delescluse I. Vian J. Peglion J.-L. Vilaine J.-P.

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.339, Iss.1, 1997-11, pp. : 43-51

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Electrophysiological Effects of a Single Intravenous Administration of Ivabradine (S 16257) in Adult Patients with Normal Baseline Electrophysiology

By Camm A.J. Lau C-P.

Drugs in R&D, Vol. 4, Iss. 2, 2003-01 ,pp. : 83-89

Adis International

Access to resources Recommend Favorite

Effect of KBT-3022, a new cyclooxygenase inhibitor, on experimental brain edema in vitro and in vivo

By Yamamoto N. Yokota K. Yamashita A. Oda M.

European Journal of Pharmacology, Vol. 297, Iss. 3, 1996-02 ,pp. : 225-231

Elsevier

Access to resources Recommend Favorite

Celecoxib is a CYP1A2 inhibitor in vitro but not in vivo

By Karjalainen Marjo Neuvonen Pertti Backman Janne

European Journal of Clinical Pharmacology, Vol. 64, Iss. 5, 2008-05 ,pp. : 511-519

Springer Publishing Company

Access to resources Recommend Favorite

In Vitro and In Vivo Antitumor Effects of Bisphosphonates

Current Medicinal Chemistry, Vol. 10, Iss. 2, 2003-01 ,pp. : 173-180

Bentham Science Publishers

Access to resources Recommend Favorite

Effect of the new imidazoline derivative S-22068 (PMS 847) on insulin secretion in vitro and glucose turnover in vivo in rats

By Pele-Tounian A. Chan S.L.F. Rondu F. Le Bihan G. Giroix M.-H. Lamouri A. Touboul E. Pfeiffer B. Manechez D. Renard P. Guardiola-Lematre B. Godfroid J.-J. Penicaud L. Morgan N.G. Ktorza A.

European Journal of Pharmacology, Vol. 377, Iss. 1, 1999-07 ,pp. : 81-87

Elsevier

Access to resources Recommend Favorite